Medication abortion with misoprostol-only: A sample protocol
Elizabeth G. Raymond, Alice Mark, Daniel Grossman, Anitra Beasley, Kristyn Brandi, Jen Castle, Mitchell D. Creinin, Caitlin Gerdts, Laura Gil, Melissa Grant, April Lockley, Jamila Perritt, Tara Shochet, Dominique Truan, Ushma D. Upadhyay
Abstract
Mifepristone approval by the United States (U.S.) Food and Drug Administration in 2000 revolutionized abortion care in this country. In 2020, 53% of people having facility-based abortions in the U.S. had medication abortions with mifepristone and misoprostol rather than uterine evacuation procedures [1]. A key advantage of medication abortion is that it can be provided entirely remotely by telemedicine and mail, which has been critical for patients who face barriers to accessing in-person services [2].
Topics & Concepts
MisoprostolMifepristoneMedicineAbortionFood and drug administrationMedical abortionFamily medicineObstetricsFamily planningProtocol (science)GynecologyPregnancyMedical emergencyAlternative medicinePopulationResearch methodologyEnvironmental healthBiologyGeneticsPathologyReproductive Health and ContraceptionMaternal and fetal healthcareMaternal and Perinatal Health Interventions